Verifying the effectiveness of medical abortion; ultrasound versus hCG testing

被引:92
作者
Fiala, C
Safar, P
Bygdeman, M
Gemzell-Danielsson, K [1 ]
机构
[1] Karolinska Hosp & Inst, Dept Women & Child Hlth, Div Obstet & Gynecol, S-17176 Stockholm, Sweden
[2] Gen Publ Hosp, Dept Obstet & Gynecol, A-2100 Korneuburg, Austria
来源
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY | 2003年 / 109卷 / 02期
关键词
medical abortion; mifepristone; hCG; ultrasound; verification of expulsion;
D O I
10.1016/S0301-2115(03)00012-5
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: The combination of mifepristone and misoprostol is an established method for termination of pregnancy. However, there is no general agreement about how best to evaluate the treatment outcome. Study design: In 217 women with an unwanted pregnancy below 49 days of amenorrhoea, ultrasound examination and serum hCG test were performed before treatment and at follow-up. Results: Treatment was successful in 98.2%. At follow-up their hCG dropped to a mean of 3% (S.D.3) of initial levels and the endometrium measured a mean of 10 mm (S.D.4). Interpretation of endometrium was difficult in some cases because of inhomogeneous structure. Using hCG was reliable in 98.5% of successful abortions. For ultrasound the corresponding figure was 89.8% for the cases with a confirmed intrauterine pregnancy before treatment but only 66% if all pregnancies were included. Conclusion: Measuring serum hCG before treatment and at follow-up is more effective than ultrasound to confirm a successful medically induced abortion in early pregnancy. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:190 / 195
页数:6
相关论文
共 13 条
  • [1] Aubeny E, 1997, CONTRACEPT FERTIL S, V25, P777
  • [2] Aubeny E, 1995, Int J Fertil Menopausal Stud, V40 Suppl 2, P85
  • [3] Bygdeman M, 2000, J Am Med Womens Assoc (1972), V55, P195
  • [4] CROWN-RUMP LENGTH AND SERUM HUMAN CHORIONIC-GONADOTROPIN AS PREDICTORS OF GESTATIONAL-AGE
    CHERVENAK, FA
    BRIGHTMAN, RC
    THORNTON, J
    BERKOWITZ, GS
    DAVID, S
    [J]. OBSTETRICS AND GYNECOLOGY, 1986, 67 (02) : 210 - 213
  • [5] Use of various ultrasonographic criteria to evaluate the efficacy of mifepristone and misoprostol for medical abortion
    Creinin, MD
    Spitz, IM
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 181 (06) : 1419 - 1424
  • [6] ELRAFAEY H, 1995, NEW ENGL J MED, V332, P983
  • [7] JOURDAN MC, 1991, INTERT BETA HCG DATA
  • [8] EARLY TERMINATION OF PREGNANCY WITH MIFEPRISTONE (RU-486) AND THE ORALLY ACTIVE PROSTAGLANDIN MISOPROSTOL
    PEYRON, R
    AUBENY, E
    TARGOSZ, V
    SILVESTRE, L
    RENAULT, M
    ELKIK, F
    LECLERC, P
    ULMANN, A
    BAULIEU, EE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (21) : 1509 - 1513
  • [9] CRITICAL EVALUATION OF SONAR CROWN-RUMP LENGTH MEASUREMENTS
    ROBINSON, HP
    FLEMING, JEE
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1975, 82 (09): : 702 - 710
  • [10] Early pregnancy termination with mifepristone and misoprostol in the United States
    Spitz, IM
    Bardin, CW
    Benton, L
    Robbins, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (18) : 1241 - 1247